Armistice Capital, LLC 13D and 13G filings for Voyager Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 5:24 pm Purchase |
2024-12-31 | 13G | Voyager Therapeutics, Inc. VYGR |
Armistice Capital, LLC | 5,396,000 9.880% |
196,000 (+3.77%) |
Filing |
| 2024-11-14 5:12 pm Purchase |
2024-09-30 | 13G | Voyager Therapeutics, Inc. VYGR |
Armistice Capital, LLC | 5,200,000 9.540% |
964,000 (+22.76%) |
Filing |
| 2024-02-14 2:35 pm Purchase |
2023-12-31 | 13G | Voyager Therapeutics, Inc. VYGR |
Armistice Capital, LLC | 4,236,000 9.630% |
840,000 (+24.73%) |
Filing |
| 2023-02-14 1:44 pm Purchase |
2022-12-31 | 13G | Voyager Therapeutics, Inc. VYGR |
Armistice Capital, LLC | 3,396,000 8.800% |
3,396,000 (New Position) |
Filing |
| 2022-02-14 9:54 pm Sale |
2021-12-31 | 13G | Voyager Therapeutics, Inc. VYGR |
Armistice Capital, LLC | 0 0.000% |
-3,392,000 (Position Closed) |
Filing |
| 2021-02-16 5:11 pm Purchase |
2020-12-31 | 13G | Voyager Therapeutics, Inc. VYGR |
Armistice Capital, LLC | 3,392,000 9.100% |
1,392,000 (+69.60%) |
Filing |